Envisionit receives FDA clearance for Radify system

Envisionit Deep AI has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the company's AI-assisted chest x-ray system, Radify.

The system has been cleared for triaging pneumothorax and pleural effusion. The company highlighted that Radify showed high accuracy in triaging both pathologies, within an average of three seconds to alert healthcare professionals.

Envisionit added that the system was evaluated using diverse data and subgroup analysis through Ratify, a standalone AI Validation and Quality Assurance tool in the company’s product suite.

Page 1 of 376
Next Page